Novabridge BiosciencesNBP
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 38 institutions reported holding Novabridge Biosciences (NBP) in their 13F filings, down 1 from Q1 2024. 3 opened new positions and 4 sold out. The largest holders were HHLR Advisors, LTD. ($11.5M), Caligan Partners LP ($5.6M) and Boothbay Fund Management, LLC ($2.3M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Novabridge Biosciences
- Filed as
- I MAB (Q2 2024)
- CUSIP
- 44975P103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $570K |
| Exits | 4 | $457K |
All 13F filers, Q1 2024 → Q2 2024: 3,949,079 shares bought and 1,002,972 shares sold, net +2,946,107 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| HHLR Advisors, LTD. | 0.28% | No change | 6,909,220 | $11.5M |
| Caligan Partners LP | 1.32% | Add +346.1% | 3,374,791 | $5.6M |
| Boothbay Fund Management, LLC | 0.08% | Add +264.6% | 1,379,352 | $2.3M |
| Two Sigma Advisers, LP | 0.00% | Reduce -6.6% | 576,600 | $963K |
| Temasek Holdings (Private) Ltd | 0.00% | No change | 566,650 | $946K |
| Two Sigma Investments, LP | 0.00% | Reduce -16.9% | 478,442 | $799K |
| Gsa Capital Partners LLP | 0.03% | Reduce -37.1% | 272,193 | $455K |
| Exome Asset Management LLC | 0.40% | Reduce -16.7% | 271,400 | $453K |
| Bank of Montreal | 0.00% | New | 244,875 | $453K |
| EDBI Pte Ltd | 0.42% | No change | 222,136 | $371K |
| Aberdeen Group plc | 0.00% | No change | 162,580 | $272K |
| State Street Corp. | 0.00% | Reduce -6.7% | 102,961 | $172K |
| Alberta Investment Management Corp | 0.00% | No change | 74,723 | $125K |
| Renaissance Technologies | 0.00% | No change | 63,800 | $107K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -3.4% | 58,358 | $97K |
| Invesco Ltd. | 0.00% | Reduce -32.0% | 57,933 | $97K |
| Millennium Management | 0.00% | Reduce -56.9% | 40,308 | $67K |
| Citadel Advisors | 0.00% | New | 38,708 | $65K |
| Geode Capital Management, LLC | 0.00% | No change | 34,347 | $57K |
| Mariner, LLC | 0.00% | No change | 31,535 | $53K |
| Susquehanna International Group, LLP | 0.00% | New | 31,066 | $52K |
| Barclays PLC | 0.00% | Reduce -21.2% | 30,370 | $51K |
| Donald L. Hagan, LLC | 0.03% | No change | 30,000 | $50K |
| XTX Topco Ltd | 0.00% | Reduce -41.4% | 17,876 | $30K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -81.5% | 15,750 | $26K |
| Marshall Wace, LLP | 0.00% | Reduce -80.2% | 14,064 | $23K |
| Morgan Stanley | 0.00% | Add +37.3% | 13,880 | $23K |
| UBS Group AG | 0.00% | Add +840.2% | 12,514 | $21K |
| BlackRock Inc. | 0.00% | Reduce -3.0% | 7,684 | $13K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -36.9% | 2,565 | $4K |
| Rhumbline Advisers | 0.00% | Reduce -0.3% | 1,367 | $2K |
| Legal & General Group Plc | 0.00% | No change | 1,191 | $2K |
| Bank of America Corp. | 0.00% | Reduce -97.0% | 568 | $949 |
| Frazier Financial Advisors, LLC | 0.00% | Add +37.3% | 515 | $861 |
| Catalyst Funds Management Pty Ltd | 0.00% | Reduce -99.9% | 90 | $150 |
| GAMMA Investing LLC | 0.00% | No change | 63 | $105 |
| Citigroup Inc. | 0.00% | No change | 50 | $84 |
| Royal Bank of Canada | 0.00% | Reduce -91.2% | 145 | $0 |
"% of holder's portfolio" is NBP's weight in each manager's 13F, not the share of Novabridge Biosciences the manager owns.